These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2613486)

  • 21. Clinical features of renal amyloidosis: an analysis of 40 patients in a 28-year follow-up.
    Tsai SF; Wen MC; Cheng CH; Wu MJ; Chen CH; Yu TM; Chuang YW; Huang ST; Shu KH
    Intern Med; 2011; 50(21):2511-7. PubMed ID: 22041350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal abnormalities that cause hypertension versus those that cause uraemia.
    Guyton AC; Manning RD; Hall JE; Young DB
    Neth J Med; 1984; 27(4):117-23. PubMed ID: 6377101
    [No Abstract]   [Full Text] [Related]  

  • 23. Renal amyloidosis.
    Szalay E; Varga I
    Acta Morphol Acad Sci Hung; 1967; 15(1):81-92. PubMed ID: 6031354
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience.
    Ozawa M; Komatsuda A; Ohtani H; Nara M; Sato R; Togashi M; Takahashi N; Wakui H
    Clin Exp Nephrol; 2017 Apr; 21(2):212-227. PubMed ID: 27116248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Arterial hypertension in renal amyloidosis (a clinico-morphological analysis)].
    Iargin SV; Pal'tsev MA; Vinogradova OM; Mukharliamova LIu
    Arkh Patol; 1987; 49(6):47-54. PubMed ID: 3662848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal amyloidosis followed more than 5 years: report of 12 cases.
    Kaaroud H; Boubaker K; Béji S; Abderrahim E; Moussa FB; Turki S; Goucha R; Hedri H; El Younsi F; Kheder A; Maiz HB
    Transplant Proc; 2004; 36(6):1796-8. PubMed ID: 15350480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients.
    Gertz MA; Kyle RA; O'Fallon WM
    Arch Intern Med; 1992 Nov; 152(11):2245-50. PubMed ID: 1444684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results, principles and pitfalls in the management of renal AA-amyloidosis; a 10-21 year followup of 16 patients with rheumatic disease treated with alkylating cytostatics.
    Berglund K; Thysell H; Keller C
    J Rheumatol; 1993 Dec; 20(12):2051-7. PubMed ID: 8014932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes and survival in AA amyloidosis patients.
    Ayar Y; Ersoy A; Oksuz MF; Ocakoglu G; Vuruskan BA; Yildiz A; Isiktas E; Oruc A; Celikci S; Arslan I; Sahin AB; Güllülü M
    Rev Bras Reumatol Engl Ed; 2017; 57(6):535-544. PubMed ID: 29173691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of chronic renal insufficiency. A study of the incidence and pattern of renal insufficiency in adults during 1966-1971 in Gothenburg.
    Ahlmén J
    Acta Med Scand Suppl; 1975; 582():1-50. PubMed ID: 1059327
    [No Abstract]   [Full Text] [Related]  

  • 31. Presentation, survival and prognostic markers in AA amyloidosis.
    Joss N; McLaughlin K; Simpson K; Boulton-Jones JM
    QJM; 2000 Aug; 93(8):535-42. PubMed ID: 10924536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors for renal amyloidosis: a clinicopathological study using cluster analysis.
    Sasatomi Y; Sato H; Chiba Y; Abe Y; Takeda S; Ogahara S; Murata T; Kaneoka H; Takebayashi S; Iwasaki H; Saito T
    Intern Med; 2007; 46(5):213-9. PubMed ID: 17329915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obstructive nephropathy and uraemia--a multi-disciplinary approach.
    Gold CH; Mausenbaum E; van Blerk PJ
    S Afr J Surg; 1977 Dec; 15(4):185-90. PubMed ID: 613452
    [No Abstract]   [Full Text] [Related]  

  • 34. Early intensification and autologous stem cell transplantation in patients with systemic AL amyloidosis: a single-centre experience.
    Frossard V; Ketterer N; Rosselet A; Meier P; Cairoli A; Duchosal MA; Kovacsovics T
    Ann Hematol; 2009 Jul; 88(7):681-5. PubMed ID: 19066891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of AA amyloidosis complicating Crohn's disease: a clinico-pathological study.
    Denis MA; Cosyns JP; Persu A; Dewit O; de Galocsy C; Hoang P; Maldague P; Wallemacq P; Zerbib F; Fiasse R
    Eur J Clin Invest; 2013 Mar; 43(3):292-301. PubMed ID: 23373823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adrenocortical insufficiency in renal amyloidosis].
    Gmar-Bouraoui S; Achour A; Abbes M; Mahjoub S; Frih A; Skhiri H; Ben Dhia N; El May M
    Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 1):4-6. PubMed ID: 11240401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal anoxia and the traumatic uraemia syndrome.
    DARMADY EM
    Br J Surg; 1947 Jan; 34(135):262-71. PubMed ID: 20289112
    [No Abstract]   [Full Text] [Related]  

  • 38. Peripheral neuropathy as an early marker of AL amyloidosis.
    Duston MA; Skinner M; Anderson J; Cohen AS
    Arch Intern Med; 1989 Feb; 149(2):358-60. PubMed ID: 2537065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal involvement in AL amyloidosis: the facts, the promise and the hope.
    Ronco P; Aucouturier P
    Nephrol Dial Transplant; 2009 Oct; 24(10):2967-9. PubMed ID: 19675063
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevalence and outcome of renal impairment at prostatectomy.
    Hill AM; Philpott N; Kay JD; Smith JC; Fellows GJ; Sacks SH
    Br J Urol; 1993 Apr; 71(4):464-8. PubMed ID: 8499992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.